{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T11:58:38Z","timestamp":1784030318385,"version":"3.55.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"NHLBI","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008497","name":"Boston Scientific Corp","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008497","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Clinical Electrophysiology"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.jacep.2023.06.009","type":"journal-article","created":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T13:58:07Z","timestamp":1693403887000},"page":"2122-2131","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Effect of Carvedilol vs Metoprolol on\u00a0Atrial and Ventricular Arrhythmias\u00a0Among Implantable Cardioverter-Defibrillator Recipients"],"prefix":"10.1016","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3989-9813","authenticated-orcid":false,"given":"Alexander","family":"Diamond","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilan","family":"Goldenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2485-5025","authenticated-orcid":false,"given":"Arwa","family":"Younis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ido","family":"Goldenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramya","family":"Sampath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Kutyifa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita Y.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"McNitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bronislava","family":"Polonsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan S.","family":"Steinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wojciech","family":"Zareba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet K.","family":"Akta\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jacep.2023.06.009_bib1","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1471-2261-13-52","article-title":"Beta-blockers for the prevention of sudden cardiac death in heart failure patients: a meta-analysis of randomized controlled trials","volume":"13","author":"Al-Gobari","year":"2013","journal-title":"BMC Cardiovasc Disord"},{"issue":"2","key":"10.1016\/j.jacep.2023.06.009_bib2","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1046\/j.1472-8206.2001.00019.x","article-title":"Beta-blocker treatment in heart failure","volume":"15","author":"Bouzamondo","year":"2001","journal-title":"Fundam Clin Pharmacol"},{"issue":"9146","key":"10.1016\/j.jacep.2023.06.009_bib3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(98)11181-9","article-title":"The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial","volume":"353","year":"1999","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.jacep.2023.06.009_bib4","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1067\/mhj.2002.120768","article-title":"Bisoprolol for the treatment of chronic heart failure: a meta-analysis on individual data of 2 placebo-controlled studies\u2014CIBIS and CIBIS II","volume":"143","author":"Leizorovicz","year":"2002","journal-title":"Am Heart J"},{"issue":"9169","key":"10.1016\/j.jacep.2023.06.009_bib5","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/S0140-6736(99)04440-2","article-title":"Effect of metoprolol CR\/XL in chronic heart failure: Metoprolol CR\/XL Randomised Intervention Trial in Congestive Heart\u00a0Failure (MERIT-HF)","volume":"353","year":"1999","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.jacep.2023.06.009_bib6","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1001\/jama.283.10.1295","article-title":"Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR\/XL Randomized Intervention Trial in Congestive Heart\u00a0Failure (MERIT-HF)","volume":"283","author":"Hjalmarson","year":"2000","journal-title":"JAMA"},{"issue":"9A","key":"10.1016\/j.jacep.2023.06.009_bib7","doi-asserted-by":"crossref","first-page":"13B","DOI":"10.1016\/j.amjcard.2004.01.018","article-title":"Landmark study: the Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction Study (CAPRICORN)","volume":"93","author":"Colucci","year":"2004","journal-title":"Am J Cardiol"},{"issue":"21","key":"10.1016\/j.jacep.2023.06.009_bib8","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM199605233342101","article-title":"The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart\u00a0Failure Study Group","volume":"334","author":"Packer","year":"1996","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.jacep.2023.06.009_bib9","first-page":"20","article-title":"The Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trial","volume":"2","author":"Eichhorn","year":"2001","journal-title":"Curr Control Trials Cardiovasc Med"},{"issue":"17","key":"10.1016\/j.jacep.2023.06.009_bib10","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/j.jacc.2021.12.011","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Heidenreich","year":"2022","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"9377","key":"10.1016\/j.jacep.2023.06.009_bib11","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(03)13800-7","article-title":"Carvedilol Or Metoprolol European Trial Investigators. Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial","volume":"362","author":"Poole-Wilson","year":"2003","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.jacep.2023.06.009_bib12","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.amjcard.2012.11.031","article-title":"Meta-analysis of carvedilol versus beta 1 selective beta-blockers (atenolol, bisoprolol, metoprolol, and nebivolol)","volume":"111","author":"DiNicolantonio","year":"2013","journal-title":"Am J Cardiol"},{"issue":"3","key":"10.1016\/j.jacep.2023.06.009_bib13","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.amjcard.2013.10.020","article-title":"Meta-analysis comparing carvedilol versus metoprolol for the prevention of postoperative atrial fibrillation following coronary artery bypass grafting","volume":"113","author":"DiNicolantonio","year":"2014","journal-title":"Am J Cardiol"},{"issue":"6","key":"10.1016\/j.jacep.2023.06.009_bib14","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0002-9149(03)00842-7","article-title":"Comparison of effectiveness of carvedilol versus metoprolol or atenolol for atrial fibrillation appearing after coronary artery bypass grafting or cardiac valve operation","volume":"92","author":"Merritt","year":"2003","journal-title":"Am J Cardiol"},{"issue":"7","key":"10.1016\/j.jacep.2023.06.009_bib15","first-page":"62","article-title":"Carvedilol and its combination with digoxin for heart rate control in patients with persistent atrial fibrillation and chronic heart failure","volume":"5","author":"Tereshchenko","year":"2022","journal-title":"Cardiovasc Ther Prev"},{"issue":"7","key":"10.1016\/j.jacep.2023.06.009_bib16","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.3390\/biomedicines10071759","article-title":"Impact of R-carvedilol on \u03b22-adrenergic receptor-mediated spontaneous calcium release in human atrial myocytes","volume":"10","author":"Casabella-Ram\u00f3n","year":"2022","journal-title":"Biomedicines"},{"issue":"9","key":"10.1016\/j.jacep.2023.06.009_bib17","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/j.1540-8159.2005.00200.x","article-title":"Electrophysiologic effects of carvedilol: is carvedilol an antiarrhythmic agent?","volume":"28","author":"El-Sherif","year":"2005","journal-title":"Pacing Clin Electrophysiol"},{"issue":"14","key":"10.1016\/j.jacep.2023.06.009_bib18","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.jacc.2007.09.073","article-title":"MADIT II Investigators. Inappropriate implantable cardioverter-defibrillator shocks in MADIT II","volume":"51","author":"Daubert","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.jacep.2023.06.009_bib19","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/j.1540-8167.2011.02279.x","article-title":"Comparison between atrial fibrillation-triggered implantable cardioverter-defibrillator (ICD) shocks and inappropriate shocks caused by lead failure: different impact on prognosis in clinical practice","volume":"23","author":"Kleemann","year":"2012","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"issue":"12","key":"10.1016\/j.jacep.2023.06.009_bib20","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa013474","article-title":"MADIT II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction","volume":"346","author":"Moss","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacep.2023.06.009_bib21","author":"Zareba"},{"issue":"14","key":"10.1016\/j.jacep.2023.06.009_bib22","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1056\/NEJMoa0906431","article-title":"Cardiac-resynchronization therapy for the prevention of heart-failure events","volume":"361","author":"Moss","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"24","key":"10.1016\/j.jacep.2023.06.009_bib23","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1056\/NEJMoa1211107","article-title":"MADIT-RIT Trial Investigators. Reduction in inappropriate therapy and mortality through ICD programming","volume":"367","author":"Moss","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.jacep.2023.06.009_bib24","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.jacc.2018.04.086","article-title":"RAID Trial Investigators. Ranolazine in high-risk patients with implanted cardioverter-defibrillators: the RAID trial","volume":"72","author":"Zareba","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.jacep.2023.06.009_bib25","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1214\/aos\/1176350951","article-title":"A\u00a0class of K-sample tests for comparing the cumulative incidence of a competing risk","volume":"16","author":"Gray","year":"1988","journal-title":"Ann Stat"},{"issue":"5","key":"10.1016\/j.jacep.2023.06.009_bib26","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S0895-7061(98)00017-X","article-title":"Hemodynamic differences between metoprolol and carvedilol in hypertensive patients","volume":"11","author":"Weber","year":"1998","journal-title":"Am J Hypertens"},{"issue":"3","key":"10.1016\/j.jacep.2023.06.009_bib27","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1161\/CIRCHEARTFAILURE.108.806240","article-title":"Mechanisms underlying improvements in ejection fraction with carvedilol in heart failure","volume":"2","author":"Maurer","year":"2009","journal-title":"Circ Heart Fail"},{"issue":"2","key":"10.1016\/j.jacep.2023.06.009_bib28","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.cardfail.2006.10.011","article-title":"Carvedilol improves left atrial and left ventricular function and reserve in dilated cardiomyopathy after 1 year of treatment","volume":"13","author":"Paraskevaidis","year":"2007","journal-title":"J\u00a0Card Fail"},{"issue":"4","key":"10.1016\/j.jacep.2023.06.009_bib29","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/clc.4960280403","article-title":"Carvedilol\u2019s antiarrhythmic properties: therapeutic implications in patients with left ventricular dysfunction","volume":"28","author":"Naccarelli","year":"2005","journal-title":"Clin Cardiol"},{"issue":"5","key":"10.1016\/j.jacep.2023.06.009_bib30","doi-asserted-by":"crossref","first-page":"H1245","DOI":"10.1152\/ajpheart.00650.2019","article-title":"Effect of carvedilol on atrial excitation-contraction coupling, Ca2+ release, and arrhythmogenicity","volume":"318","author":"Martinez-Hernandez","year":"2020","journal-title":"Am J Physiol-Heart Circ Physiol"},{"issue":"18","key":"10.1016\/j.jacep.2023.06.009_bib31","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1161\/CIRCULATIONAHA.108.821306","article-title":"Atrial fibrillation and heart failure","volume":"119","author":"Anter","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jacep.2023.06.009_bib32","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ahj.2016.08.003","article-title":"ORBIT AF Investigators and Patients. Patient factors associated with quality of life in atrial fibrillation","volume":"182","author":"Randolph","year":"2016","journal-title":"Am Heart J"},{"issue":"6","key":"10.1016\/j.jacep.2023.06.009_bib33","doi-asserted-by":"crossref","first-page":"4808","DOI":"10.1002\/ehf2.13668","article-title":"Newly diagnosed atrial fibrillation and hospital utilization in heart failure: a nationwide cohort study","volume":"8","author":"Vinter","year":"2021","journal-title":"ESC Heart Fail"},{"issue":"6A","key":"10.1016\/j.jacep.2023.06.009_bib34","doi-asserted-by":"crossref","first-page":"2D","DOI":"10.1016\/S0002-9149(02)03373-8","article-title":"Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy","volume":"91","author":"Maisel","year":"2003","journal-title":"Am J Cardiol"},{"issue":"2","key":"10.1016\/j.jacep.2023.06.009_bib35","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1161\/CIRCEP.110.957670","article-title":"Posttraumatic stress and the implantable cardioverter-defibrillator patient","volume":"4","author":"Sears","year":"2011","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"15","key":"10.1016\/j.jacep.2023.06.009_bib36","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.jacc.2013.03.087","article-title":"Impact of carvedilol and metoprolol on inappropriate implantable cardioverter-defibrillator therapy","volume":"62","author":"Ruwald","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.jacep.2023.06.009_bib37","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jacc.2004.11.034","article-title":"Three decades of clinical trials with beta-blockers","volume":"45","author":"Pratt","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.jacep.2023.06.009_bib38","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.ahj.2004.10.002","article-title":"COMET Investigators. Effects of metoprolol and carvedilol on cause-specific mortality and morbidity in patients with chronic heart failure\u2014COMET","volume":"149","author":"Torp-Pedersen","year":"2005","journal-title":"Am Heart J"},{"issue":"14","key":"10.1016\/j.jacep.2023.06.009_bib39","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1016\/j.jacc.2013.01.020","article-title":"Effect of metoprolol versus carvedilol on outcomes in MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy)","volume":"61","author":"Ruwald","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"suppl 5","key":"10.1016\/j.jacep.2023.06.009_bib40","first-page":"V11","article-title":"Prevention of sudden cardiac death with beta blockers","volume":"22","author":"Hjalmarson","year":"1999","journal-title":"Clin Cardiol"},{"issue":"2 suppl 1","key":"10.1016\/j.jacep.2023.06.009_bib41","first-page":"25","article-title":"The role of beta-blockers in preventing sudden death in heart failure","volume":"6","author":"Teerlink","year":"2000","journal-title":"J\u00a0Card Fail"},{"issue":"6","key":"10.1016\/j.jacep.2023.06.009_bib42","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.pcad.2007.12.001","article-title":"The role of antiarrhythmic drug therapy for the prevention of sudden cardiac death","volume":"50","author":"Kamath","year":"2008","journal-title":"Prog Cardiovasc Dis"},{"issue":"3","key":"10.1016\/j.jacep.2023.06.009_bib43","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0008-6363(97)00293-9","article-title":"Experimental evidence for proarrhythmic mechanisms of antiarrhythmic drugs","volume":"37","author":"Nattel","year":"1998","journal-title":"Cardiovasc Res"},{"issue":"2","key":"10.1016\/j.jacep.2023.06.009_bib44","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.tcm.2003.12.002","article-title":"Cellular basis of triggered arrhythmias in heart failure","volume":"14","author":"Pogwizd","year":"2004","journal-title":"Trends Cardiovasc Med"},{"issue":"9","key":"10.1016\/j.jacep.2023.06.009_bib45","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1161\/01.CIR.0000117254.68497.39","article-title":"Altered calcium handling is critically involved in the cardiotoxic effects of chronic beta-adrenergic stimulation","volume":"109","author":"Engelhardt","year":"2004","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.jacep.2023.06.009_bib46","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1161\/res.90.1.14","article-title":"Calcium and cardiac rhythms: physiological and pathophysiological","volume":"90","author":"Bers","year":"2002","journal-title":"Circ Res"},{"issue":"7","key":"10.1016\/j.jacep.2023.06.009_bib47","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1161\/01.RES.0000093399.11734.B3","article-title":"Elevated sarcoplasmic reticulum Ca2+ leak in intact ventricular myocytes from rabbits in heart failure","volume":"93","author":"Shannon","year":"2003","journal-title":"Circ Res"},{"issue":"8","key":"10.1016\/j.jacep.2023.06.009_bib48","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/nm.2406","article-title":"Carvedilol and its new analogs suppress arrhythmogenic store overload-induced Ca2+ release","volume":"17","author":"Zhou","year":"2011","journal-title":"Nat Med"},{"issue":"11","key":"10.1016\/j.jacep.2023.06.009_bib49","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1161\/01.CIR.94.11.2807","article-title":"Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators","volume":"94","author":"Bristow","year":"1996","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.jacep.2023.06.009_bib50","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0735-1097(02)01970-8","article-title":"Dose of metoprolol CR\/XL and clinical outcomes in patients with heart failure: analysis of the experience in metoprolol CR\/XL randomized intervention trial in chronic heart failure (MERIT-HF)","volume":"40","author":"Wikstrand","year":"2002","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacep.2023.06.009_bib51","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/europace\/euw408","article-title":"The use of guideline recommended beta-blocker therapy in primary prevention implantable cardioverter-defibrillator patients: insight from Danish nationwide registers","volume":"20","author":"Ruwald","year":"2018","journal-title":"Europace"},{"key":"10.1016\/j.jacep.2023.06.009_bib52","doi-asserted-by":"crossref","first-page":"f217","DOI":"10.1093\/europace\/euy077","article-title":"Importance of beta-blocker dose in prevention of ventricular tachyarrhythmias, heart failure hospitalizations, and death in primary prevention implantable cardioverter-defibrillator recipients: a Danish nationwide cohort study","volume":"20","author":"Ruwald","year":"2018","journal-title":"Europace"},{"issue":"10254","key":"10.1016\/j.jacep.2023.06.009_bib53","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S0140-6736(20)31824-9","article-title":"SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials","volume":"396","author":"Zannad","year":"2020","journal-title":"Lancet"},{"issue":"15","key":"10.1016\/j.jacep.2023.06.009_bib54","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1161\/CIRCULATIONAHA.119.044183","article-title":"Effect of dapagliflozin on atrial fibrillation in patients with type 2 diabetes mellitus: insights from the DECLARE-TIMI 58 trial","volume":"141","author":"Zelniker","year":"2020","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.jacep.2023.06.009_bib55","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.hrthm.2021.03.028","article-title":"Association of SGLT2 inhibitors with arrhythmias and sudden cardiac death in patients with type 2 diabetes or heart failure: a meta-analysis of 34 randomized controlled trials","volume":"18","author":"Fernandes","year":"2021","journal-title":"Heart Rhythm"}],"container-title":["JACC: Clinical Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405500X23004449?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405500X23004449?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T07:32:57Z","timestamp":1762500777000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405500X23004449"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":55,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S2405500X23004449"],"URL":"https:\/\/doi.org\/10.1016\/j.jacep.2023.06.009","relation":{},"ISSN":["2405-500X"],"issn-type":[{"value":"2405-500X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of Carvedilol vs Metoprolol on\u00a0Atrial and Ventricular Arrhythmias\u00a0Among Implantable Cardioverter-Defibrillator Recipients","name":"articletitle","label":"Article Title"},{"value":"JACC: Clinical Electrophysiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacep.2023.06.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}